Teva Pharmaceutical Industries Limited (NYSE: TEVA) open the trading on March 16, 2023, with a bit cautious approach as it glided -1.96% to $8.50. During the day, the stock rose to $8.59 and sunk to $8.36 before settling in for the price of $8.67 at the close. Taking a more long-term approach, TEVA posted a 52-week range of $6.78-$11.44.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -7.80%. Meanwhile, its Annual Earning per share during the time was 34.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -662.70%. This publicly-traded company’s shares outstanding now amounts to $1.11 billion, simultaneously with a float of $1.10 billion. The organization now has a market capitalization sitting at $9.91 billion. At the time of writing, stock’s 50-day Moving Average stood at $10.16, while the 200-day Moving Average is $9.08.
Let’s gauge the efficiency of the firm, which has a total of 34004 employees. It has generated 1,360,727 per worker during the last fiscal year. Meanwhile, its income per employee was -214,683. The stock had 3.69 Receivables turnover and 0.33 Total Asset turnover. For the Profitability, stocks gross margin was +46.68, operating margin was +17.96 and Pretax Margin of -20.55.
Teva Pharmaceutical Industries Limited (TEVA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Teva Pharmaceutical Industries Limited’s current insider ownership accounts for 2.00%, in contrast to 49.60% institutional ownership. According to the most recent insider trade that took place on Mar 07, this organization’s EVP, North America Commercial sold 58,066 shares at the rate of 9.43, making the entire transaction reach 547,440 in total value, affecting insider ownership by 165,381. Preceding that transaction, on Mar 07, Company’s Exec. VP, European Commercial sold 54,007 for 9.43, making the whole transaction’s value amount to 509,173. This particular insider is now the holder of 69,770 in total.
Teva Pharmaceutical Industries Limited (TEVA) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2022 suggests? It has posted $0.71 earnings per share (EPS) beating the forecaster’s viewpoint (set at $0.71) by $0. This company achieved a net margin of -15.78 while generating a return on equity of -26.42. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.57 per share during the current fiscal year.
Teva Pharmaceutical Industries Limited’s EPS decrease for this current 12-month fiscal period is -662.70% and is forecasted to reach 2.53 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 3.60% through the next 5 years, which can be compared against the 34.30% growth it accomplished over the previous five years trading on the market.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Trading Performance Indicators
Let’s observe the current performance indicators for Teva Pharmaceutical Industries Limited (TEVA). It’s Quick Ratio in the last reported quarter now stands at 0.70. The Stock has managed to achieve an average true range (ATR) of 0.29. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.66. Similarly, its price to free cash flow for trailing twelve months is now 9.51.
In the same vein, TEVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.12, a figure that is expected to reach 0.56 in the next quarter, and analysts are predicting that it will be 2.53 at the market close of one year from today.
Technical Analysis of Teva Pharmaceutical Industries Limited (TEVA)
[Teva Pharmaceutical Industries Limited, TEVA] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 8.02% While, its Average True Range was 0.29.
Raw Stochastic average of Teva Pharmaceutical Industries Limited (TEVA) in the period of the previous 100 days is set at 15.74%, which indicates a major rise in contrast to 7.87% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 29.36% that was lower than 36.83% volatility it exhibited in the past 100-days period.